跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 15, 2023
Approval ID
5ef7c3cbea83a2ad
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
5ef7c3cbea83a2ad
Drug Cima Aemps Name
AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88445
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2023-03-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
AMBRISENTAN
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 15, 2023
Approval ID
5ef7c3cbea83a2ad
Type
Standard
Back to CIMA-AEMPS Approvals
AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details